Shares of Enovix Corporation (ENVX) nosedived 20% in pre-market trading on Friday, as investors reacted negatively to the company's third-quarter guidance despite a better-than-expected second-quarter earnings report. The stark contrast between the Q2 performance and Q3 outlook has raised concerns about the lithium-ion battery manufacturer's growth trajectory and path to profitability.

Enovix reported impressive Q2 results, with revenue reaching $7.47 million, surpassing analyst expectations of $6.34 million and marking a robust 98% year-over-year increase. The company's adjusted loss per share of 13 cents also beat the anticipated loss of 17 cents. Enovix highlighted key achievements, including the launch of its AI-1 cell platform and a third consecutive quarter of positive gross margin, demonstrating progress in product development, manufacturing readiness, and commercialization efforts.

However, the company's Q3 guidance has sparked investor concerns. Enovix projects third-quarter revenue between $7.5 million and $8.5 million, only marginally above the current quarter's performance. The forecasted loss of 14 to 18 cents per share for Q3 further indicates ongoing challenges. Despite maintaining a strong cash position of $203.4 million, the market's severe reaction suggests deep-seated worries about the pace of growth for the innovative battery maker. This disappointing outlook, contrasting sharply with the Q2 beat, appears to be the primary driver behind the significant pre-market stock plunge.